Suppliers / Delpharm Boucherville Canada

Delpharm Boucherville Canada

Canada 228 employees Updated 9 July 2026

Delpharm Boucherville Canada is a finished-dose manufacturer based in Canada. It appears in 5 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), EDE (AE) and INVIMA (CO). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 26 January 2024 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
5
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 26 January 2024 VAI US FDA
  • 11 February 2020 NAI US FDA
  • 12 June 2018 NAI US FDA
  • 9 August 2016 NAI US FDA
  • 22 October 2013 VAI US FDA
  • 4 August 2011 OAI US FDA
  • 15 July 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Boucherville, United Arab Emirates Not on file
Canada, Canada 3000280957

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 2 None
EDE (AE) 2 None
INVIMA (CO) 1 None
US FDA None 1

Questions about Delpharm Boucherville Canada

Does Delpharm Boucherville Canada hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Delpharm Boucherville Canada. It does have 5 filings with 3 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Delpharm Boucherville Canada FDA-registered?
One site operated by Delpharm Boucherville Canada carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Delpharm Boucherville Canada's last inspection go?
The most recent inspection on record closed on 26 January 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 7 inspections are on file, of which 1 closed as OAI.
Where does Delpharm Boucherville Canada manufacture?
2 registered sites are on record, in United Arab Emirates and Canada (Boucherville and Canada). Every site is listed on this page with the register it came from.
Which regulators recognise Delpharm Boucherville Canada's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Delpharm Boucherville Canada comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 26 January 2024.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates